This chronic, low-grade inflammatory state is recognized as a key pathological mechanism underlying sarcopenia, where inflammatory mediators like TNF-α and IL-6, activated through the NF-κB signalling pathway, inhibit muscle protein synthesis and accelerate muscle protein breakdown (Bian et al., 2017; Xuekel et al., 2024). The gene discussed is NFKB1; the disease is sarcopenia.